A Phase I Trial of Bendamustine in Combination With Clofarabine and Etoposide in Pediatric Patients With Relapsed or Refractory Hematologic Malignancies
Latest Information Update: 23 Feb 2021
At a glance
- Drugs Bendamustine (Primary) ; Clofarabine; Dexamethasone; Etoposide
- Indications Acute biphenotypic leukaemia; Acute myeloid leukaemia; Haematological malignancies; Hodgkin's disease; Lymphoma; Non-Hodgkin's lymphoma; Precursor B-cell lymphoblastic leukaemia-lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma; Precursor T-cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Acronyms BECHEM
- 17 Feb 2021 Results published in the Cancer
- 21 Mar 2017 Status changed from recruiting to completed.
- 28 Aug 2013 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov record.